These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2435999)

  • 41. Effect of slow release nifedipine tablets in patients with essential hypertension.
    Imai Y; Abe K; Munakata M; Sasaki S; Minami N; Sakuma H; Hashimoto J; Watanabe N; Sakuma M; Sekino H
    Arzneimittelforschung; 1992 Dec; 42(12):1434-8. PubMed ID: 1288507
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of daily anti-hypertensive effects of amlodipine and nifedipine coat-core using ambulatory blood pressure monitoring - utility of "hypobaric curve" and "hypobaric area".
    Kuga K; Xu DZ; Ohtsuka M; Aonuma K; Lau AH; Watanabe Y; Ohtsuka K
    Clin Exp Hypertens; 2011; 33(4):231-9. PubMed ID: 21699449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma concentrations and hemodynamic effects of nifedipine: a study in anesthetized dogs.
    Hamann SR; McAllister RG
    J Cardiovasc Pharmacol; 1983; 5(6):920-7. PubMed ID: 6196563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative pharmacokinetics and antihypertensive effects of the nifedipine tablet and capsule.
    Myers MG; Raemsch KD
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S76-8. PubMed ID: 2455148
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of nimodipine on hemodynamic parameters and peak and trough plasma concentrations of nifedipine chronically administered to elderly hypertensive patients.
    Breuel HP; Mück W; Heine PR; Schmage N; Niklaus H; Kuhlmann J
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):109-13. PubMed ID: 7757309
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of hypertensive urgencies and emergencies with nitrendipine, nifedipine, and clonidine: effect on blood pressure and heart rate.
    Späh F; Grosser KD
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S154-6. PubMed ID: 2468862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hemodynamic and antianginal effects during rest and exercise of intravenous isradipine, a new dihydropyridine calcium antagonist.
    Burger W; Neidel S; Kober G
    Clin Cardiol; 1989 Jul; 12(7):393-8. PubMed ID: 2525975
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemodynamic effects of isradipine and nifedipine in chronic sustained hypertension.
    Gross P; Koppenhagen K; Wudel E; Burger KJ; Welzel D; Distler GA
    J Cardiovasc Pharmacol; 1992; 19 Suppl 3():S84-6. PubMed ID: 1376845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nicardipine versus nifedipine: multicentre controlled trial in essential hypertension.
    Rumboldt Z; Stojanova D; Drinovec J; Marinković M; Nesović M; Srbinovski M; Bagatin J; Nikodijević B; Stalc A
    Int J Clin Pharmacol Res; 1988; 8(6):393-400. PubMed ID: 3075601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nifedipine improves left ventricular function in patients with hypertension.
    Zusman RM; Christensen DM; Higgins J; Boucher CA
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):843-8. PubMed ID: 1725896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Central hemodynamic changes of calcium antagonists at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1987; 10 Suppl 1():S139-48. PubMed ID: 2442506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and safety of sublingual nifedipine in hypertensive emergencies.
    Ellrodt AG; Ault MJ; Riedinger MS; Murata GH
    Am J Med; 1985 Oct; 79(4A):19-25. PubMed ID: 4050842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics and pharmacodynamics of nifedipine in children with bronchopulmonary dysplasia and pulmonary hypertension.
    Johnson CE; Beekman RH; Kostyshak DA; Nguyen T; Oh DM; Amidon GL
    Pediatr Res; 1991 May; 29(5):500-3. PubMed ID: 1896255
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A randomized, double-blind, hemodynamic evaluation of nifedipine and labetalol in preeclamptic hypertensive emergencies.
    Scardo JA; Vermillion ST; Newman RB; Chauhan SP; Hogg BB
    Am J Obstet Gynecol; 1999 Oct; 181(4):862-6. PubMed ID: 10521743
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Felodipine pharmacokinetics and plasma concentration vs effect relationships.
    Blychert E
    Blood Press Suppl; 1992; 2():1-30. PubMed ID: 1343111
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardiac and hemodynamic adjustments to rapid and sustained blood pressure reduction.
    Phillips RA; Ardeljan M; Goldman ME; Eison HB; Krakoff LR
    Am J Hypertens; 1989 Jun; 2(6 Pt 2):196S-199S. PubMed ID: 2751849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidine.
    van Harten J; van Brummelen P; Lodewijks MT; Danhof M; Breimer DD
    Clin Pharmacol Ther; 1988 Mar; 43(3):332-41. PubMed ID: 3345623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodynamic and humoral effects of the angiotensin II antagonist losartan in essential hypertension.
    Grossman E; Peleg E; Carroll J; Shamiss A; Rosenthal T
    Am J Hypertens; 1994 Dec; 7(12):1041-4. PubMed ID: 7702796
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spectrum of acute hemodynamic effects of nifedipine in severe congestive heart failure.
    Elkayam U; Weber L; McKay C; Rahimtoola S
    Am J Cardiol; 1985 Sep; 56(8):560-6. PubMed ID: 4036843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.